Skip to Main Content.

Site navigation

Fidelity.com Home

Customer Service
Profile
Open an Account
Refer a Friend
Log In

Customer Service
Profile
Open an Account
Refer a Friend
Log Out

Search fidelity.com or get a quote

Accounts & Trade
Planning & Advice
News & Research
Investment Products
Why Fidelity

Customer Service
Profile
Open an Account
Refer a Friend
Log In

Customer Service
Profile
Open an Account
Refer a Friend
Log Out

Content and data provided by various third parties and Fidelity − Terms of Use

Research >
Stocks >
News & Events >

Stock Details

Enter Company or Symbol. Press down arrow for suggestions, or Escape to return to entry field.

View this information for the company or symbol View this information for the company or symbol

Find Symbol. Opens in new window.

Snapshot
Detailed Quote
Advanced Chart &
Technical Analysis
News & Events
Compare
Analyst Opinions
Research Reports
Key Statistics
Earnings
Dividends
Ownership & Insiders
Financial Statements
SEC Filings

RELATED RESOURCES

Stock Research Overview
Stock Screeners
Markets & Sectors
Fidelity Learning Center

Print Format

Change Text Size:

Default text sizeA
Larger text sizeA
Largest text sizeA

Form SC 13G/A bluebird bio, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP

BY 10K Wizard
— 9:11 AM ET 01/11/2021

http://archive.fast-edgar.com/20210111/A22AV2224222S2Z2222T22OZPLQ7Z2Q2B232

Filed on: January 11, 2021

More BLUE News

BRIEF-Verastem Oncology Appoints Frank Neumann, M.D., Ph.D., As Chief Medical Officer
Reuters - 9:28 AM ET 01/06/2021
Shape Therapeutics Announces Appointment of Gary Fortin as Chief Operating Officer
Business Wire - 8:00 AM ET 12/08/2020
BRIEF-Bluebird Bio Inc Announces New Data From Group C Of Its Ongoing Phase 1/2 Hgb-206 Study Of Investigational Lentiglobin Gene Therapy
Reuters - 5:45 PM ET 12/07/2020

Copyright 1998–2021 FMR LLC.
All rights reserved.

Terms of Use|
Privacy|
Security|
Site Map